Breakthrough in Alzheimer’s research: examining the pros and cons of two promising new drugs
The emergence of two new drugs to treat Alzheimer’s disease provides a rare burst of hope for the field of Alzheimer’s research.
The emergence of two new drugs to treat Alzheimer’s disease provides a rare burst of hope for the field of Alzheimer’s research.
Scientists from Japan conducted a study suggesting that an oxytocin derivative may help reduce the cognitive decline seen in Alzheimer’s disease.
Eisai Co. and partner Biogen Inc. said their drug significantly slowed Alzheimer’s disease, making it the first medicine to blunt progression of the most common dementia in a definitive, large-scale trial.Â
Specialised video games promise a workout for your brain. Scientists are studying whether they can ward off dementia.
This article explains that new research indicates that people with cardiometabolic multimorbidities are more likely to experience accelerated cognitive decline and conversion to dementia.
There are currently an estimated 50 million families round the world affected by Alzheimer’s disease at a cost of $1trn a year to the global economy.
Prof Thomas Merritt writes about the antioxidants linked to good health that coffee contains and how it may help to prevent cancer and dementia.
Marc Agronin, a geriatric psychiatrist, lists things you need to keep in mind before you start panicking over memory loss.
This article outlines the benefits that all forms of dance can bestow, particularly on ageing people, the current and most fascinating research being on how the socialising, cognitive and physical benefits of dance can prevent dementia.
Millions are caring for a loved one with dementia at home, and turning to tracking and monitoring devices to help manage the daily struggle.